This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1:
Spatial and temporal aspects of intratumoral heterogeneity. The progression of the disease in the course of time culminates in cancer cells’ variation within and among primary and metastatic NSCLC.
Figure 2:
Schematic representation of intratumoral heterogeneity mechanisms and levels.